In MS patients, generic GA suppressed IL-17 mRNA expression in CD4+ T cells at a concentration of 200 μg/ml, while original GA at concentrations of 100 μg/ml and 200 μg/ml (Fig 3A). The gene discussed is CD4; the disease is myeloid sarcoma.